Effects of urotensin II on isolated rat hearts under normal perfusion and ischemia-reperfusion

Acta Physiologica Sinica

Volumn 55, Issue 4, 2003, Pages 442-448

  Zhou, Ping ^a   Wu, Sheng Ying ^a   Yu, Cheng Fan ^a   Wang, Hua ^a   Tang, Chao Shu ^a,b   Lin, Li ^c   Yuan, Wen Jun ^c  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Ischemia reperfusion; Isolated heart perfusion; Pathology; Rat; Urotensin II

Indexed keywords

IODINE 125; LACTATE DEHYDROGENASE; MALONALDEHYDE; MYOGLOBIN; UROTENSIN II;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL MEMBRANE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; DRUG EFFECT; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PERFUSION; HEART RATE; ISOLATED HEART; NONHUMAN; RAT;

ANIMALS; FEMALE; HEART; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; UROTENSINS;

EID: 0042324172     PISSN: 03710874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Moore G, Letter A, Tesanovic M, Lederis K. Studies on molecular weights of two peptide hormones from the urophysis of white sucker (Catostomus commersoni). Can J Biochem 1975;53(2):242-247.
2. Coulouarn Y, Lihrmann I, Jegou S, Anouar Y, Tostivint H, Beauvillain JC, Conlon JM, Bern HA, Vaudry R. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci USA 1998; 95(26):15803-15808.
3. Coulouarn Y, Jegou S, Tostivint H, Vaudry H, Lihrmann I. Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett 1999;457(1):28-32.
4. Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, Ao Z, Disa J, Holmes SD, Stadel JM, Martin JD, Liu WS, Glover GI, Wilson S, McNulty DE, Ellis CE, Elshourbagy NA, Shabon U, Trill JJ, Hay DW, Douglas SA. Human urotensin-II: a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 1999;401(6750):282-286.
5. Liu Q, Pong SS, Zeng Z, Zhang Q, Howard AD, Williams DL, Davidoff M, Wang R, Austin CP, McDonald TP, Bai C, George SR, Evans JF, Caskey CT. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun 1999;266(1):174-178.
6. Maguire JJ, Kuc RE, Davenport AP. Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol 2000;131(3):441-446.
7. Douglas SA, Ashton DJ, Sauermelch CF, Coatney RW, Ohlstein DH, Ruffolo MR, Ohlstein EH, Aiyar NV, Willette RN. Human urotensin- II is a potent vasoactive peptide: pharmacological characterization in the rat, mouse, dog and primate. J Cardiovasc Pharmacol 2000; 36(5 Suppl 1):S163-S166).
8. Bottrill FE, Douglas SA, Hiley CR, White R. Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries. Br J Pharmacol 2000;130(8):1865-1870.
9. Katano Y, Ishihata A, Aita T, Ogaki T, Horie T. Vasodilator effect of urotensin II, one of the most potent vasoconstricting factors, on rat coronary arteries. Eur J Pharmacol 2000;402(1-2):R5-R7.
10. Russell FD, Molenaar P, O'Brien DM. Cardiostimulant effects of urotensin-II in human heart in vitro. Br J Pharmacol 2001;132(1):5-9.
11. Richards AM, Nicholls MG, Lainchbury JG, Fisher S, Yandle TG. Plasma urotensin II in heart failure. Lancet 2002;360(9332):545-546.
12. Douglas SA, Tayara L, Ohlstein EH, Halawa N, Giaid A. Congestive heart failure and expression of myocardial urotensin II. Lancet 2002; 359(9322):1990-1997.
13. Merin RG. The isolated heart preparation. Br J Anaesth 1988, 60(8 Suppl 1):28S-34S.
14. Elz JS, Nayler WG. Quantification of calcium paradox in neonatal rat hearts. Am J Physiol 1987;253(6 Pt 2): H1358-H1364.
15. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95(2):351-358.
16. Itoh H, McMaster D, Lederis K. Functional receptors for fish neuropeptide urotensin II in major rat arteries. Eur J Pharmacol 1988;149(1-2):61-66.
17. Zhang Y, Li J, Cao J, Chen J, Yang J, Zhang Z, Du J, Tang C. Effect of chronic hypoxia on contents of urotensin II and its functional receptors in rat myocardium. Heart Vessels 2002;16(2):64-68.
18. Evans JF, CT Caske. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun 1999;266 (1):174-178.
19. Wilkinson IB, Affolter JT, de-Haas SL, Pellegrini MP, Boyd J, Winter MJ, Balment RJ, Webb DJ. High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man. Cardiovasc Res 2002;53(2):341-347.
20. Gibson A, Conyers H, Bern HA. The influence of urotensin II on calcium flux in rat aorta. J Pharm Pharmacol 1988;40(12):893-895.
21. Rossowski WJ, Cheng BL, Taylor JE, Datta R, Coy DH. Human urotensin II -induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists. Eur J Pharmacol 2002;438(3):159-170.